# Stereotactic Ablative Radiotherapy for Refractory Ventricular Tachycardia

> **NCT03349892** · NA · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 1 (actual)

## Conditions studied

- Refractory Ventricular Tachycardia

## Interventions

- **RADIATION:** Stereotactic Ablative Radiotherapy (SABR)

## Key facts

- **NCT ID:** NCT03349892
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-01
- **Primary completion:** 2019-08-06
- **Final completion:** 2019-08-06
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2021-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03349892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03349892, "Stereotactic Ablative Radiotherapy for Refractory Ventricular Tachycardia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03349892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*